IgA Antibody - #DF8563
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# DF8563, RRID:AB_2841767.
Fold/Unfold
FLJ14473; FLJ35065; FLJ35500; FLJ36402; FLJ39698; FLJ40001; FLJ41548; FLJ41552; FLJ41789; FLJ43248; FLJ43594; FLJ44293; FLJ46028; FLJ46621; FLJ46724; FLJ46811; FLJ46824; FLJ90170; Ig alpha 1 chain C region; IgA1; IGHA1; immunoglobulin heavy constant alpha 1; MGC102857; A2m marker; Ig alpha 2 chain C region; IgA constant heavy chain 2; IGHA 2; IGHA2; IGHA2 protein; Immunoglobulin A2; Immunoglobulin Am2; immunoglobulin heavy constant alpha 2 (A2m marker); Immunoglobulin heavy constant alpha 2;
Immunogens
A synthesized peptide derived from human IgA, corresponding to a region within C-terminal amino acids.
- P01876 IGHA1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDASGDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSPSCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLCGCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEELALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRVAAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY
- P01877 IGHA2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
ASPTSPKVFPLSLDSTPQDGNVVVACLVQGFFPQEPLSVTWSESGQNVTARNFPPSQDASGDLYTTSSQLTLPATQCPDGKSVTCHVKHYTNSSQDVTVPCRVPPPPPCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGATFTWTPSSGKSAVQGPPERDLCGCYSVSSVLPGCAQPWNHGETFTCTAAHPELKTPLTANITKSGNTFRPEVHLLPPPSEELALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTYAVTSILRVAAEDWKKGETFSCMVGHEALPLAFTQKTIDRMAGKPTHINVSVVMAEADGTCY
PTMs - P01876/P01877 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
K88 | Ubiquitination | Uniprot | |
N144 | N-Glycosylation | Uniprot | |
K168 | Ubiquitination | Uniprot | |
K200 | Ubiquitination | Uniprot | |
T201 | Phosphorylation | Uniprot | |
C204 | S-Nitrosylation | Uniprot | |
K212 | Ubiquitination | Uniprot | |
C250 | S-Nitrosylation | Uniprot | |
K258 | Ubiquitination | Uniprot | |
K275 | Ubiquitination | Uniprot | |
K306 | Ubiquitination | Uniprot | |
K307 | Ubiquitination | Uniprot | |
C313 | S-Nitrosylation | Uniprot | |
K327 | Ubiquitination | Uniprot | |
T328 | Phosphorylation | Uniprot | |
K335 | Ubiquitination | Uniprot | |
N340 | N-Glycosylation | Uniprot |
Site | PTM Type | Enzyme | Source |
---|---|---|---|
N47 | N-Glycosylation | Uniprot | |
N92 | N-Glycosylation | Uniprot | |
N131 | N-Glycosylation | Uniprot | |
K155 | Ubiquitination | Uniprot | |
N205 | N-Glycosylation | Uniprot | |
K245 | Ubiquitination | Uniprot | |
K262 | Ubiquitination | Uniprot | |
K293 | Ubiquitination | Uniprot | |
K294 | Ubiquitination | Uniprot | |
K314 | Ubiquitination | Uniprot | |
N327 | N-Glycosylation | Uniprot |
Research Backgrounds
Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen. Ig alpha is the major immunoglobulin class in body secretions.
3-Hydroxykynurenine, an oxidized tryptophan metabolite that is common in biological fluids, reacts with alpha-1-microglobulin to form heterogeneous polycyclic chromophores including hydroxanthommatin. The chromophore reacts with accessible cysteines forming non-reducible thioether cross-links with Ig alpha-1 chain C region Cys-352.
N- and O-glycosylated. N-glycan at Asn-144: Hex5HexNAc4.
Secreted. Cell membrane.
Immunoglobulins are composed of two identical heavy chains and two identical light chains; disulfide-linked. Monomeric or polymeric.
Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen. Ig alpha is the major immunoglobulin class in body secretions.
Secreted. Cell membrane.
Immunoglobulins are composed of two identical heavy chains and two identical light chains; disulfide-linked. Monomeric or polymeric.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.